Logo image of CNVI.CA

CONAVI MEDICAL CORP (CNVI.CA) Stock Fundamental Analysis

TSX-V:CNVI - CA2059531020 - Common Stock

0.45 CAD
-0.02 (-4.26%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

2

Overall CNVI gets a fundamental rating of 2 out of 10. We evaluated CNVI against 16 industry peers in the Health Care Equipment & Supplies industry. While CNVI seems to be doing ok healthwise, there are quite some concerns on its profitability. CNVI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNVI had negative earnings in the past year.
CNVI had a negative operating cash flow in the past year.
CNVI had negative earnings in 4 of the past 5 years.
CNVI had negative operating cash flow in 4 of the past 5 years.
CNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

CNVI has a Return On Assets of -315.92%. This is comparable to the rest of the industry: CNVI outperforms 43.75% of its industry peers.
The Return On Equity of CNVI (-720.07%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -315.92%
ROE -720.07%
ROIC N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVI.CA Yearly ROA, ROE, ROICCNVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

1.3 Margins

In the last couple of years the Operating Margin of CNVI has grown nicely.
CNVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVI.CA Yearly Profit, Operating, Gross MarginsCNVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

CNVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNVI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNVI has more shares outstanding
The debt/assets ratio for CNVI has been reduced compared to a year ago.
CNVI.CA Yearly Shares OutstandingCNVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CNVI.CA Yearly Total Debt VS Total AssetsCNVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -120.29, we must say that CNVI is in the distress zone and has some risk of bankruptcy.
CNVI's Altman-Z score of -120.29 is on the low side compared to the rest of the industry. CNVI is outperformed by 81.25% of its industry peers.
CNVI has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
CNVI has a Debt to Equity ratio of 0.26. This is in the better half of the industry: CNVI outperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -120.29
ROIC/WACCN/A
WACC7.86%
CNVI.CA Yearly LT Debt VS Equity VS FCFCNVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

CNVI has a Current Ratio of 2.21. This indicates that CNVI is financially healthy and has no problem in meeting its short term obligations.
CNVI has a Current ratio of 2.21. This is amongst the best in the industry. CNVI outperforms 87.50% of its industry peers.
CNVI has a Quick Ratio of 2.21. This indicates that CNVI is financially healthy and has no problem in meeting its short term obligations.
CNVI has a Quick ratio of 2.21. This is amongst the best in the industry. CNVI outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
CNVI.CA Yearly Current Assets VS Current LiabilitesCNVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CNVI have decreased strongly by -2034.76% in the last year.
CNVI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.70%.
Measured over the past years, CNVI shows a small growth in Revenue. The Revenue has been growing by 6.56% on average per year.
EPS 1Y (TTM)-2034.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-894.37%
Revenue 1Y (TTM)-50.7%
Revenue growth 3Y6.56%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CNVI will show a very negative growth in Earnings Per Share. The EPS will decrease by -42.31% on average per year.
CNVI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.94% yearly.
EPS Next YN/A
EPS Next 2Y-163.53%
EPS Next 3Y-64.76%
EPS Next 5Y-42.31%
Revenue Next YearN/A
Revenue Next 2Y-39.77%
Revenue Next 3Y-38.01%
Revenue Next 5Y-15.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNVI.CA Yearly Revenue VS EstimatesCNVI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2025 2026 2027 5M 10M 15M 20M 25M
CNVI.CA Yearly EPS VS EstimatesCNVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2025 2026 2027 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CNVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVI.CA Price Earnings VS Forward Price EarningsCNVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVI.CA Per share dataCNVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A cheap valuation may be justified as CNVI's earnings are expected to decrease with -64.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-163.53%
EPS Next 3Y-64.76%

More info and screens

0

5. Dividend

5.1 Amount

CNVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONAVI MEDICAL CORP

TSX-V:CNVI (9/3/2025, 7:00:00 PM)

0.45

-0.02 (-4.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-10 2025-11-10
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap34.54M
Analysts80
Price Target1.02 (126.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)36.04%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.97
P/FCF N/A
P/OCF N/A
P/B 17.52
P/tB 17.52
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.11
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -315.92%
ROE -720.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.42%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z -120.29
F-Score1
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)113.75%
Cap/Depr(5y)424.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2034.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-894.37%
EPS Next YN/A
EPS Next 2Y-163.53%
EPS Next 3Y-64.76%
EPS Next 5Y-42.31%
Revenue 1Y (TTM)-50.7%
Revenue growth 3Y6.56%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2Y-39.77%
Revenue Next 3Y-38.01%
Revenue Next 5Y-15.94%
EBIT growth 1Y-186.24%
EBIT growth 3Y43%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.14%
OCF growth 3YN/A
OCF growth 5YN/A